April 6, 2022
Daily corticosteroid use is significantly more effective than an intermittent regimen for improving motor function in patients with Duchenne muscular dystrophy (DMD), a new study suggests. […]
April 5, 2022
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Neuroendoscopy for the treatment […]
April 4, 2022
The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The investigators attempted to […]
April 4, 2022
SEATTLE – The latest data from a phase 3 clinical trial shows that gene therapy can counter visual degeneration associated with Leber hereditary optic neuropathy (LHON). […]
April 1, 2022
The study covered in this summary was published in researchsquare.com and has not yet been peer reviewed. This case–control study provided supportive evidence that previous proton […]
April 1, 2022
Patients with persistent cognitive impairment months after illness with mild COVID-19 have higher levels of inflammatory markers in their cerebrospinal fluid (CSF). Researchers found elevated levels […]
March 31, 2022
The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways In patients with chronic […]
March 31, 2022
Early results from a small trial of an investigative drug suggests it is safe and may improve executive function in patients with mild cognitive impairment (MCI) […]
March 31, 2022
A US Food and Drug Association (FDA) advisory panel has concluded there’s not enough evidence to support approval of a new drug to treat amyotrophic lateral […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141
Next page